UNP
42
4
EMR
56
6
F
36
2
ADSK
57
9
WFC
66
3
HPE
40
8
SPG
43
3
ETN
69
8
TRIP
37
11
CB
46
2
CI
50
-2
PFG
42
5
FIS
63
8
CNX
42
-8
AMG
54
2
RCL
76
3
QRVO
60
3
NSC
65
5
VNO
59
4
CMG
48
7
UNP
42
4
EMR
56
6
F
36
2
ADSK
57
9
WFC
66
3
HPE
40
8
SPG
43
3
ETN
69
8
TRIP
37
11
CB
46
2
CI
50
-2
PFG
42
5
FIS
63
8
CNX
42
-8
AMG
54
2
RCL
76
3
QRVO
60
3
NSC
65
5
VNO
59
4
CMG
48
7
Financhill
Back

Alaunos Therapeutics 10K Form

Sell
37

TCRT
Alaunos Therapeutics

Last Price:
$3.17
Seasonality Move:
0.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TCRT News And Ratings

See the #1 stock for the next 7 days that we like better than TCRT

TCRT Financial Statistics

Sales & Book Value

Annual Sales: $10K
Cash Flow: $-772K
Price / Cash Flow: 0
Annual Sales: $0.66
Price / Book: 4.95

Profitability

EPS (TTM): -2.54000
Net Income (TTM): $-4.1M
Gross Margin: $0
Return on Equity: -141.23%
Return on Assets: -106.35%

Alaunos Therapeutics Earnings Forecast

Key Alaunos Therapeutics Financial Ratios

  • The Selling, General & Administrative Expenses for TCRT have been equal to 44,600.00% of Gross Profit Margin.
  • The Research & Development expenses have been 3,620.00% of Revenue.
  • The Net Earning history of TCRT is -46,790.00% of Total Revenues.
  • Per Share Earnings over the last 24 years have been positive in 14 years.

Alaunos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: TCRT
Website: alaunos.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 1
Quick Ratio: 0.3

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TCRT Technical Analysis vs Fundamental Analysis

Sell
37
Alaunos Therapeutics (TCRT) is a Sell

Is Alaunos Therapeutics a Buy or a Sell?